alizarin has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doll, MA; Habil, MR; Hein, DW; Leggett, CS; Salazar-González, RA; Trent, JO | 1 |
| Avnet, S; Baldini, N; Fotia, C; Granchi, D | 1 |
2 other study(ies) available for alizarin and Breast Neoplasms
| Article | Year |
|---|---|
Identification and characterization of potent, selective, and efficacious inhibitors of human arylamine N-acetyltransferase 1.
Topics: Animals; Anthraquinones; Arylamine N-Acetyltransferase; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; DNA Adducts; DNA Breaks, Double-Stranded; Enzyme Inhibitors; Hepatocytes; Humans; Inhibitory Concentration 50; Isoenzymes | 2022 |
The natural compound Alizarin as an osteotropic drug for the treatment of bone tumors.
Topics: Anthraquinones; Bone Marrow Cells; Bone Neoplasms; Breast Neoplasms; Carcinoma; Cell Cycle; Cell Line, Tumor; Cell Transformation, Neoplastic; Drug Screening Assays, Antitumor; Humans; MAP Kinase Signaling System; Osteosarcoma | 2012 |